Literature DB >> 22776780

Type-1 cannabinoid receptor signaling in neuronal development.

Anne-Lise Gaffuri1, Delphine Ladarre, Zsolt Lenkei.   

Abstract

The type-1 cannabinoid receptor (CB1R) was initially identified as the neuronal target of Δ(9)-tetrahydrocannabinol (THC), the major psychoactive substance of marijuana. This receptor is one of the most abundant G-protein-coupled receptors in the adult brain, the target of endocannabinoid ligands and a well-characterized retrograde synaptic regulator. However, CB1Rs are also highly and often transiently expressed in neuronal populations in the embryonic and early postnatal brain, even before the formation of synapses. This suggests important physiological roles for CB1Rs during neuronal development. Several recent reviews have summarized our knowledge about the role of the endocannabinoid (eCB) system in neurodevelopment and neurotransmission by focusing on the metabolism of endocannabinoid molecules. Here, we review current knowledge about the effects of the modulation of CB1R signaling during the different phases of brain development. More precisely, we focus on reports that directly implicate CB1Rs during progenitor cell migration and differentiation, neurite outgrowth, axonal pathfinding and synaptogenesis. Based on theoretical considerations and on the reviewed experimental data, we propose a new model to explain the diversity of experimental findings on eCB signaling on neurite growth and axonal pathfinding. In our model, cell-autonomus and paracrine eCBs acting on CB1Rs are part of a global inhibitory network of cytoskeletal effectors, which act in concert with positive-feedback local-excitation loops, to ultimately yield highly polarized neurons.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776780     DOI: 10.1159/000339075

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  29 in total

1.  Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons.

Authors:  Önder Albayram; Stefan Passlick; Andras Bilkei-Gorzo; Andreas Zimmer; Christian Steinhäuser
Journal:  Pflugers Arch       Date:  2016-01-07       Impact factor: 3.657

2.  Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice.

Authors:  Abigail E Agoglia; Sarah E Holstein; Vallari R Eastman; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2016-01-19       Impact factor: 3.533

Review 3.  Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history.

Authors:  Diana Dow-Edwards; Ashley Frank; Dean Wade; Jeremy Weedon; Sari Izenwasser
Journal:  Neurotoxicol Teratol       Date:  2016-09-12       Impact factor: 3.763

Review 4.  CB1 and CB2 Receptor Pharmacology.

Authors:  Allyn C Howlett; Mary E Abood
Journal:  Adv Pharmacol       Date:  2017-06-12

5.  Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.

Authors:  Cui'e Lu; Yue Liu; Bei Sun; Yu'e Sun; Bailing Hou; Yu Zhang; Zhengliang Ma; Xiaoping Gu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

Review 6.  A review on neuroimaging studies of genetic and environmental influences on early brain development.

Authors:  Wei Gao; Karen Grewen; Rebecca C Knickmeyer; Anqi Qiu; Andrew Salzwedel; Weili Lin; John H Gilmore
Journal:  Neuroimage       Date:  2018-04-16       Impact factor: 6.556

7.  Prenatal marijuana exposure predicts marijuana use in young adulthood.

Authors:  Kristen E Sonon; Gale A Richardson; Jack R Cornelius; Kevin H Kim; Nancy L Day
Journal:  Neurotoxicol Teratol       Date:  2014-11-13       Impact factor: 3.763

8.  Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat.

Authors:  Lindsay Silva; Lauren Harte-Hargrove; Sari Izenwasser; Ashley Frank; Dean Wade; Diana Dow-Edwards
Journal:  Neurosci Lett       Date:  2015-06-26       Impact factor: 3.046

9.  Differential expression and functional role of cannabinoid genes in alcohol users.

Authors:  Marisela Agudelo; Adriana Yndart; Marisol Morrison; Gloria Figueroa; Karla Muñoz; Thangavel Samikkannu; Madhavan P Nair
Journal:  Drug Alcohol Depend       Date:  2013-09-05       Impact factor: 4.492

Review 10.  Adverse health effects of marijuana use.

Authors:  Nora D Volkow; Ruben D Baler; Wilson M Compton; Susan R B Weiss
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.